PRXIQ yields 2000000.00% · PFE yields 6.13%● Live data
📍 PRXIQ pulled ahead of the other in Year 1
Combined, PRXIQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRXIQ + PFE for your $10,000?
Premier Exhibitions, Inc., together with its subsidiaries, engages in presenting museum-quality touring exhibitions to public worldwide. It operates through two segments, Exhibition Management and RMS Titanic. It develops, deploys, operates, and presents exhibition products in exhibition centers, museums, and non-traditional venues. The company operates and manages various exhibitions, such as 'Titanic: The Artifact Exhibition' that features the artifacts recovered from the wreck site; Titanic: The Experience, a Titanic-themed exhibition; and 'Bodies...The Exhibition' and 'Bodies Revealed', which display multiple human anatomy sets that contain a collection of whole human body specimens, and single human organs and body parts. It also operates and manages 'Pompeii: One Day in Pompeii', which features the artifacts recovered from the debris of the city of Pompeii; 'Real Pirates' that tells the story of the Whydah, the first authenticated pirate shipwreck in U.S. waters, and the stories of the people whose lives converged on the vessel; and 'The Discovery of King Tut', an exhibition based on King Tutankhamun. In addition, the company sells merchandise, such as apparel, posters, gifts, and jewelry related to its shows over the Internet; publishes exhibition catalogs; and provides ancillary services, such as audio tours, as well as sells visitor exhibition themed photographs at its exhibition gift shops. Premier Exhibitions, Inc. was founded in 1987 and is based in Peachtree Corners, Georgia.
Full PRXIQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.